Accenture (NYSE: ACN) announced that Endurance Specialty Holding, Ltd.,
a global specialty provider of property and casualty (P&C) insurance and
reinsurance, has gone into production with Accenture
Duck Creek Policy and Rating
software to support its diverse worldwide client portfolio.
Enduro Royalty Trust (NYSE: NDRO) (the “Trust”) today announced a cash
distribution to the holders of its units of beneficial interest of
$0.064625 per unit, payable on November 17, 2014 to unitholders of
record on October 31, 2014.
Energy Transfer Equity, L.P. (NYSE: ETE) today announced that its
Board of Directors has approved a $0.035 increase in its quarterly cash
distribution to $0.415 per ETE common unit for the third quarter ended
September 30, 2014, or $1.66 per unit on an annualized basis.
Energy Transfer Partners, L.P. (NYSE: ETP) today announced
that its Board of Directors has approved a $0.02 increase in its
quarterly distribution to $0.975 per ETP common unit ($3.90 annualized)
for the quarter ended September 30, 2014.
Solar Power International 2014 – Booth 812 – Enphase Energy, Inc.
(NASDAQ: ENPH), today announced the Enphase
Energy Management System , a groundbreaking system for energy
management that delivers on the vision of enabling large-scale
implementation of solar power integrated with the grid.
ESB Financial Corporation (Nasdaq: ESBF), the parent company of ESB
Bank, today announced earnings for the quarter ended September 30, 2014
of $0.26 per diluted share on net income of $4.6 million compared to
earnings of $0.23 per diluted share on net income of $4.0 million for
the quarter ended September 30, 2013, a 13.0% increase in net income per
Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical
company focused on developing and commercializing first-in-class, oral
low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies
for the treatment of hypercholesterolemia and other cardiometabolic risk
markers, today announced the closing of its follow-on public offering of
4,887,500 shares of common stock, offered at a price to the public of
$20.00 per share, which includes the exercise in full by the
underwriters of their option to purchase 637,500 additional shares of
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and
joint restoration products for hip, knee, shoulder and spine, announced
today revenue of $57.9 million for the third quarter of 2014, a 4%
increase over $55.7 million in the third quarter of 2013.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.